Vitamin K plays a key role in the synthesis of several blood coagulation factors, but it is also involved in bone metabolism and vascular calcification. There are two forms of vitamin K: K1 and K2, which may behave differently. Oral anticoagulation with warfarin inhibits the vitamin K system. Although warfarin reduces ischemic stroke, there are concerns on hemorrhagic complications and, due to the impaired activity of other vitamin K-dependent proteins such as osteocalcin (or BGP, bone Gla protein) and MGP (matrix Gla protein), on an increased burden of bone fractures and vascular calcifications. These in turn may be significant determinants of morbidity and mortality. The geriatric population, who is often affected by bone disorders frequently related to aging itself, could benefit from a supplementation of vitamin K, but further studies are necessary to prove actual benefits, both in CKD patients and in the general population. In patients at risk of vascular calcifications and fractures, in particular elderly patients affected by CKD, the possible beneficial role of vitamin K supplementation, as well as more a selected administration of vitamin K inhibitors for anticoagulation should be considered.
Vitamin K and bone metabolism in the elderly with normal and reduced kidney function / M. Gallieni, M.A. Rizzo, S. Maggi, A. Regalia, I. Molfino, G. Crepaldi, M. Fusaro. - In: EUROPEAN GERIATRIC MEDICINE. - ISSN 1878-7649. - 4:1(2013), pp. 32-38. [10.1016/j.eurger.2012.10.001]
Vitamin K and bone metabolism in the elderly with normal and reduced kidney function
M. Gallieni
;M.A. Rizzo;A. Regalia;M. Fusaro
2013
Abstract
Vitamin K plays a key role in the synthesis of several blood coagulation factors, but it is also involved in bone metabolism and vascular calcification. There are two forms of vitamin K: K1 and K2, which may behave differently. Oral anticoagulation with warfarin inhibits the vitamin K system. Although warfarin reduces ischemic stroke, there are concerns on hemorrhagic complications and, due to the impaired activity of other vitamin K-dependent proteins such as osteocalcin (or BGP, bone Gla protein) and MGP (matrix Gla protein), on an increased burden of bone fractures and vascular calcifications. These in turn may be significant determinants of morbidity and mortality. The geriatric population, who is often affected by bone disorders frequently related to aging itself, could benefit from a supplementation of vitamin K, but further studies are necessary to prove actual benefits, both in CKD patients and in the general population. In patients at risk of vascular calcifications and fractures, in particular elderly patients affected by CKD, the possible beneficial role of vitamin K supplementation, as well as more a selected administration of vitamin K inhibitors for anticoagulation should be considered.File | Dimensione | Formato | |
---|---|---|---|
Gallieni - Eur Geritatric Med 2013 preprint.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
9.68 MB
Formato
Adobe PDF
|
9.68 MB | Adobe PDF | Visualizza/Apri |
1-s2.0-S1878764912006596-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
439.91 kB
Formato
Adobe PDF
|
439.91 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.